| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Pres. Discovery&Research
1 company
Payan Donald G is an EVP, Pres. Discovery&Research at RIGEL PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2016 | RIGL Rigel Pharmaceuticals Inc | EVP, Pres. Discovery&Research | Sell | 5,303 | $4.00 | $21,214.12 | -9.1% | |
| Jun 10, 2015 | RIGL Rigel Pharmaceuticals Inc | EVP, Pres. Discovery&Research | Sale+OE | 41,666 | $3.68 | $153,214.22 | -41.7% | |
| Apr 1, 2015 | RIGL Rigel Pharmaceuticals Inc | EVP, Pres. Discovery&Research | Sell | 10,000 | $3.75 | $37,518.00 | -14.6% |